{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:55:40Z","timestamp":1794300940950,"version":"4.9.0"},"reference-count":43,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of incident alopecia (hair loss) in adults with type 2 diabetes, compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Target trial emulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Electronic health records from Penn Medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults (&gt;18 years) with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>New initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, or DPP-4 inhibitors between January 2019 and September 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Outcomes of interest included incident alopecia and its subtypes, identified by using diagnostic codes. Stabilised inverse probability of treatment weighting was applied to balance baseline covariates between treatment groups, and Cox proportional hazards models were used to estimate hazard ratios with 95% confidence intervals. Multiple sensitivity (including negative control outcome calibration) and subgroup analyses were done to assess robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 12 004 GLP-1 receptor agonist initiators and 15 221 SGLT-2 inhibitor initiators in the GLP-1 receptor agonist versus SGLT-2 inhibitor comparison and 11 964 GLP-1 receptor agonist initiators and 11 238 DPP-4 inhibitor initiators in the GLP-1 receptor agonist versus DPP-4 inhibitor comparison. After stabilised inverse probability of treatment weighting adjustment, use of GLP-1 receptor agonists was associated with a higher risk of alopecia than use of SGLT-2 inhibitors (hazard ratio 1.37, 95% confidence interval 1.08 to 1.73) or DPP-4 inhibitors (1.68, 1.28 to 2.20). The associations were consistent across sensitivity and subgroup analyses, with attenuation after negative control outcome calibration. Subtype analyses indicated that the association was specific to non-scarring alopecia, with hazard ratios of 1.53 (1.18 to 1.97) and 1.72 (1.28 to 2.31) compared with SGLT-2 inhibitors and DPP-4 inhibitors, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Use of GLP-1 receptor agonists was associated with an increased risk of non-scarring alopecia in adults with type 2 diabetes. Although the absolute risk is low, awareness of this potential effect may help to inform treatment decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj-2026-100077","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:11Z","timestamp":1784764811000},"page":"e100077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation"],"prefix":"10.1136","volume":"394","author":[{"given":"Huilin","family":"Tang","sequence":"first","affiliation":[{"name":"Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Lu","sequence":"additional","affiliation":[{"name":"Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"},{"name":"Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Computer Science, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cotsarelis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Asch","sequence":"additional","affiliation":[{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Wharton School, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-0788","authenticated-orcid":true,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"},{"name":"Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Penn Medicine Center for Evidence based Practice (CEP), University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026081311000787000_394.jul22_11.e100077.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2024-004431"},{"key":"2026081311000787000_394.jul22_11.e100077.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S008"},{"key":"2026081311000787000_394.jul22_11.e100077.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q1645"},{"key":"2026081311000787000_394.jul22_11.e100077.4","first-page":"e181","article-title":"Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists","volume":"23","author":"Ituarte","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"2026081311000787000_394.jul22_11.e100077.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.01.046"},{"key":"2026081311000787000_394.jul22_11.e100077.6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17246"},{"key":"2026081311000787000_394.jul22_11.e100077.7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20197"},{"key":"2026081311000787000_394.jul22_11.e100077.8","unstructured":"US Food and Drug Administration. July - September 2023 | Potential Signals of Serious Risks\/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS).2023. https:\/\/www.fda.gov\/drugs\/fda-adverse-event-monitoring-system-aems\/july-september-2023-potential-signals-serious-risksnew-safety-information-identified-fda-adverse."},{"key":"2026081311000787000_394.jul22_11.e100077.9","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14983"},{"key":"2026081311000787000_394.jul22_11.e100077.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.24288"},{"key":"2026081311000787000_394.jul22_11.e100077.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2025.100186"},{"key":"2026081311000787000_394.jul22_11.e100077.12","doi-asserted-by":"publisher","DOI":"10.5021\/ad.24.043"},{"key":"2026081311000787000_394.jul22_11.e100077.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.12461"},{"key":"2026081311000787000_394.jul22_11.e100077.14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20512"},{"key":"2026081311000787000_394.jul22_11.e100077.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21383"},{"key":"2026081311000787000_394.jul22_11.e100077.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-087179"},{"key":"2026081311000787000_394.jul22_11.e100077.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S009"},{"key":"2026081311000787000_394.jul22_11.e100077.18","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-015-0053-5"},{"key":"2026081311000787000_394.jul22_11.e100077.19","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5782"},{"key":"2026081311000787000_394.jul22_11.e100077.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2825"},{"key":"2026081311000787000_394.jul22_11.e100077.21","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2017.8.35985"},{"key":"2026081311000787000_394.jul22_11.e100077.22","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.329"},{"key":"2026081311000787000_394.jul22_11.e100077.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00671.x"},{"key":"2026081311000787000_394.jul22_11.e100077.24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2026081311000787000_394.jul22_11.e100077.25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5925"},{"key":"2026081311000787000_394.jul22_11.e100077.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708282114"},{"key":"2026081311000787000_394.jul22_11.e100077.27","doi-asserted-by":"publisher","DOI":"10.64898\/2026.07.08.26357550"},{"key":"2026081311000787000_394.jul22_11.e100077.28","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2026081311000787000_394.jul22_11.e100077.29","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000864"},{"key":"2026081311000787000_394.jul22_11.e100077.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.06.012"},{"key":"2026081311000787000_394.jul22_11.e100077.31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1544068"},{"key":"2026081311000787000_394.jul22_11.e100077.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270030012011"},{"key":"2026081311000787000_394.jul22_11.e100077.33","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020325"},{"key":"2026081311000787000_394.jul22_11.e100077.34","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0701a01"},{"key":"2026081311000787000_394.jul22_11.e100077.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z"},{"key":"2026081311000787000_394.jul22_11.e100077.36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030513"},{"key":"2026081311000787000_394.jul22_11.e100077.37","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.15010"},{"key":"2026081311000787000_394.jul22_11.e100077.38","doi-asserted-by":"publisher","DOI":"10.1002\/phar.70007"},{"key":"2026081311000787000_394.jul22_11.e100077.39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997578"},{"key":"2026081311000787000_394.jul22_11.e100077.40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1525623"},{"key":"2026081311000787000_394.jul22_11.e100077.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103453"},{"key":"2026081311000787000_394.jul22_11.e100077.42","first-page":"364","article-title":"Alopecia areata: autoimmune basis of hair loss","volume":"14","author":"Alexis","year":"2004","journal-title":"Eur J Dermatol"},{"key":"2026081311000787000_394.jul22_11.e100077.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.07.001"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100077","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:00:14Z","timestamp":1786644014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":43,"alternative-id":["10.1136\/bmj-2026-100077"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100077","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}